POLVERARI, GIULIA
POLVERARI, GIULIA
SCIENZE MEDICHE
18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival
2020-01-01 Polverari, Giulia; Ceci, Francesco; Bertaglia, Valentina; Reale, Maria Lucia; Rampado, Osvaldo; Gallio, Elena; Passera, Roberto; Liberini, Virginia; Scapoli, Paola; Arena, Vincenzo; Racca, Manuela; Veltri, Andrea; Novello, Silvia; Deandreis, Désirée
18F-Fluorodeoxyglucose Uptake in Patient With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Referred to Positron Emission Tomography/Computed Tomography for NSCLC Restaging
2020-01-01 Polverari G.; Arena V.; Ceci F.; Pelosi E.; Ianniello A.; Poli E.; Sandri A.; Penna D.
[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
2020-01-01 Polverari G.; Ceci F.; Passera R.; Crane J.; Du L.; Li G.; Fanti S.; Bernthal N.; Eilber F.C.; Allen-Auerbach M.; Czernin J.; Calais J.; Federman N.
Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[18F]FDG-PET study
2022-01-01 Canosa, Antonio; Martino, Alessio; Giuliani, Alessandro; Moglia, Cristina; Vasta, Rosario; Grassano, Maurizio; Palumbo, Francesca; Cabras, Sara; Di Pede, Francesca; De Mattei, Filippo; Matteoni, Enrico; Polverari, Giulia; Manera, Umberto; Calvo, Andrea; Pagani, Marco; Chiò, Adriano
Clinical application of Fluciclovine PET, choline PET and gastrin-releasing polypeptide receptor (bombesin) targeting PET in prostate cancer
2020-01-01 Ceci F.; Castellucci P.; Polverari G.; Iagaru A.
Impact of segmentation and discretization on radiomic features in 68Ga-DOTA-TOC PET/CT images of neuroendocrine tumor
2021-01-01 Liberini V.; De Santi B.; Rampado O.; Gallio E.; Dionisi B.; Ceci F.; Polverari G.; Thuillier P.; Molinari F.; Deandreis D.
Predictive accuracy and clinical benefit of a nomogram aimed to predict 68Ga-PSMA PET/CT positivity in patients with prostate cancer recurrence and PSA < 1 ng/ml external validation on a single institution database
2020-01-01 Bianchi L.; Borghesi M.; Schiavina R.; Castellucci P.; Ercolino A.; Bianchi F.M.; Barbaresi U.; Polverari G.; Brunocilla E.; Fanti S.; Ceci F.
Predictive value of baseline [18f]fdg pet/ct for response to systemic therapy in patients with advanced melanoma
2021-01-01 Liberini V.; Rubatto M.; Mimmo R.; Passera R.; Ceci F.; Fava P.; Tonella L.; Polverari G.; Lesca A.; Bello M.; Arena V.; Ribero S.; Quaglino P.; Deandreis D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival | 2020 | Polverari, Giulia; Ceci, Francesco; Bertaglia, Valentina; Reale, Maria Lucia; Rampado, Osvaldo; Gallio, Elena; Passera, Roberto; Liberini, Virginia; Scapoli, Paola; Arena, Vincenzo; Racca, Manuela; Veltri, Andrea; Novello, Silvia; Deandreis, Désirée | |
| 18F-Fluorodeoxyglucose Uptake in Patient With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Referred to Positron Emission Tomography/Computed Tomography for NSCLC Restaging | 2020 | Polverari G.; Arena V.; Ceci F.; Pelosi E.; Ianniello A.; Poli E.; Sandri A.; Penna D. | |
| [18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial | 2020 | Polverari G.; Ceci F.; Passera R.; Crane J.; Du L.; Li G.; Fanti S.; Bernthal N.; Eilber F.C.; Allen-Auerbach M.; Czernin J.; Calais J.; Federman N. | |
| Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[18F]FDG-PET study | 2022 | Canosa, Antonio; Martino, Alessio; Giuliani, Alessandro; Moglia, Cristina; Vasta, Rosario; Grassano, Maurizio; Palumbo, Francesca; Cabras, Sara; Di Pede, Francesca; De Mattei, Filippo; Matteoni, Enrico; Polverari, Giulia; Manera, Umberto; Calvo, Andrea; Pagani, Marco; Chiò, Adriano | |
| Clinical application of Fluciclovine PET, choline PET and gastrin-releasing polypeptide receptor (bombesin) targeting PET in prostate cancer | 2020 | Ceci F.; Castellucci P.; Polverari G.; Iagaru A. | |
| Impact of segmentation and discretization on radiomic features in 68Ga-DOTA-TOC PET/CT images of neuroendocrine tumor | 2021 | Liberini V.; De Santi B.; Rampado O.; Gallio E.; Dionisi B.; Ceci F.; Polverari G.; Thuillier P.; Molinari F.; Deandreis D. | |
| Predictive accuracy and clinical benefit of a nomogram aimed to predict 68Ga-PSMA PET/CT positivity in patients with prostate cancer recurrence and PSA < 1 ng/ml external validation on a single institution database | 2020 | Bianchi L.; Borghesi M.; Schiavina R.; Castellucci P.; Ercolino A.; Bianchi F.M.; Barbaresi U.; Polverari G.; Brunocilla E.; Fanti S.; Ceci F. | |
| Predictive value of baseline [18f]fdg pet/ct for response to systemic therapy in patients with advanced melanoma | 2021 | Liberini V.; Rubatto M.; Mimmo R.; Passera R.; Ceci F.; Fava P.; Tonella L.; Polverari G.; Lesca A.; Bello M.; Arena V.; Ribero S.; Quaglino P.; Deandreis D. |